Consideration before administering cytotoxic chemotherapy to the critically ill.
Tanvetyanon
Tawee
T
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003422:Critical Care; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011788:Quality of Life
D000970:Antineoplastic Agents